Delivery Order SPE2DB25D3020-SPE2DB25FWHDJ
- Not listed
- The Defense Logistics Agency awarded a $14,842.16 delivery order to AmerisourceBergen Drug Corp for Terbinafine HCL 250 mg tablets (30-count units) under a firm fixed-price contract type. The award was made on July 23, 2025, with an ultimate completion date of July 24, 2025, and does not utilize a set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor providing critical medical supply support to federal healthcare...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a delivery order from the Defense Logistics Agency (DLA) on June 17, 2025, for Truqap 200 mg tablets (64-count packaging). This firm fixed-price delivery order, valued at $15,514.40, is not designated as a set-aside contract and is scheduled for completion by July 10, 2025. The delivery will be performed at AmerisourceBergen's Conshohocken facility. This delivery order is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Triumeq 600-50-300 mg tablets (30-count units) with a ceiling value of $35,571.24. This competitively awarded, firm fixed-price delivery order will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, and is scheduled for completion by September 12, 2025. The contract carries no set-aside designation, reflecting AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Terbinafine HCL 250 mg tablets in quantities of 100s, with a ceiling value of $11,707.25. The delivery order represents a firm fixed price, competitive award with no set-aside designation and an ultimate completion date of September 17, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location....
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $7,387.08 for Terlivaz 0.85 mg vials on July 24, 2025, with completion targeted for August 14, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Terbinafine HCL 250 mg tablets in quantities of 30, with a ceiling value of $7,207.59. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement and is scheduled for completion by September 17, 2025. AmerisourceBergen's place of performance is located in Conshohocken, Pennsylvania, reflecting the company's headquarters location and...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,165.31 on August 8, 2025, for the supply of Terbinafine HCl 250 mg tablets in quantities of 30 units. This is a firm fixed price delivery order with an ultimate completion date of August 11, 2025, and represents a non-competitive, non-set-aside procurement. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for TRUQAP 160 mg tablets (16-count units) valued at $15,959.30, with a firm fixed price structure and an ultimate completion date of August 22, 2025. This non-set-aside competitive award was issued on August 1, 2025, with performance occurring at the contractor's corporate office in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's substantial Indefinite Delivery Contract with DLA...
- AmerisourceBergen Drug Corp was awarded a $2,462.36 delivery order by the Defense Logistics Agency (DLA) on July 30, 2025, for the supply of Terlivaz 0.85 mg vials, with a completion date of August 20, 2025. This is a firm fixed price, non-set-aside contract with performance at the company's Conshohocken, Pennsylvania facility. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which carries a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Terbinafine HCL 250 mg tablets in quantities of 100 units. This competitively awarded, non-set-aside contract is valued at $1,510.57 with a firm fixed price structure and an ultimate completion date of August 19, 2025. The contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- SPE2DB25D3020Indefinite Delivery Contract
- SPE2DB25D3020-SPE2DB25FWHDJDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on April 24, 2025, for the supply of Teriflunomide 14 mg tablets (28-count packaging) with a ceiling value of $9,160.13. This is a firm fixed price delivery order with no set-aside designation, awarded through competitive procedures. The order is scheduled for ultimate completion by April 25, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This prime contract vehicle enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. AmerisourceBergen, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement across multiple therapeutic domains, including specialty medications, brand-name and generic drugs, and vaccines. The company's award under this highly competitive contract reflects its demonstrated capability to meet federal medical supply requirements through the Defense Health Agency and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.2k | 4/24/25 |